Technical Specifications
| Specification | Details |
|---|---|
| Product Name | Tesamorelin |
| Chemical Classification | Synthetic Peptide |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular Weight | ~5135.9 g/mol |
| Sequence Length | 44 amino acids |
| Sequence | Modified GHRH Analog |
| Purity | ≥98% |
| Form | Lyophilized Peptide |
| Classification | Growth Hormone-Releasing Hormone Analog |
| Intended Use | Laboratory Research Only |
Product Overview
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog designed to mimic the activity of endogenous GHRH.
Its structure is based on a modified form of the GHRH sequence and includes structural modifications intended to improve peptide stability. Tesamorelin has been extensively investigated in research involving GHRH receptor signaling, growth hormone pathways, pituitary function, endocrine signaling, and peptide-receptor interactions.
The peptide provides researchers with a defined model for studying the biological mechanisms associated with GHRH-mediated signaling.
Mechanism of Action
Research has investigated Tesamorelin in relation to several biological mechanisms:
GHRH Receptor Signaling
Tesamorelin interacts with the growth hormone-releasing hormone receptor (GHRHR), providing a model for investigating GHRH-mediated cellular signaling.
Growth Hormone Pathways
Experimental studies have investigated Tesamorelin in relation to signaling pathways involved in the regulation of growth hormone secretion.
Pituitary Signaling
Research models have examined the interaction between GHRH analogs and pituitary somatotroph cells involved in growth hormone production.
cAMP Signaling
Activation of the GHRH receptor is associated with intracellular signaling involving cyclic AMP (cAMP), making Tesamorelin useful for studying endocrine signal transduction.
Peptide Stability Research
The modified structure of Tesamorelin provides a research model for investigating peptide stability, receptor interactions, and structure-function relationships.
Research Applications
Tesamorelin may be investigated in laboratory settings involving:
- GHRH receptor research
- Growth hormone signaling
- Pituitary-cell biology
- Endocrine signaling
- cAMP pathway research
- Peptide-receptor interaction studies
- Synthetic peptide research
- Structure-activity relationship studies
- Neuroendocrine research
- Hormonal signaling research
Handling & Storage
- Store the lyophilized peptide according to the manufacturer’s recommended conditions.
- Protect from excessive heat, moisture, and direct sunlight.
- Keep the product sealed in its original packaging until required for laboratory research.
- Store at approximately −20°C when consistent with supplier specifications.
- Follow the applicable batch Certificate of Analysis for exact storage requirements.
- Minimize unnecessary temperature fluctuations.
- Avoid repeated freeze-thaw cycles where applicable.
- Protect the material from prolonged exposure to moisture and light.
Product Features
✓ Research Grade Quality
✓ ≥98% Purity
✓ Modified GHRH Analog
✓ Growth Hormone-Releasing Hormone Research Compound
✓ 44-Amino-Acid Peptide
✓ Lyophilized for Stability
✓ Carefully Packaged
✓ Laboratory Research Use Only
Important Notice
This product is intended exclusively for laboratory research purposes.
It is not intended for human or veterinary use, administration, injection, consumption, diagnosis, treatment, cure, or prevention of any disease.
Tesamorelin is associated with an FDA-approved prescription medication. This research-grade material should not be represented as an equivalent, substitute, or source of an approved pharmaceutical product.
The material described here is supplied solely for laboratory investigation. Research findings should not be interpreted as established evidence of safety or efficacy for unapproved applications.
The exact purity, molecular characterization, modification status, salt form, and analytical specifications should be verified against the applicable batch Certificate of Analysis (CoA).
By purchasing this product, the purchaser acknowledges that it will be handled only by qualified professionals in appropriate laboratory environments and used in accordance with applicable laws, regulations, and institutional protocols.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic GHRH analog investigated for its interaction with growth hormone-releasing hormone receptors and related endocrine signaling pathways.
How many amino acids does Tesamorelin contain?
Tesamorelin is a 44-amino-acid peptide analog.
What is Tesamorelin researched for?
Tesamorelin is investigated in research involving GHRH receptor signaling, growth hormone pathways, pituitary-cell biology, endocrine signaling, cAMP pathways, and peptide-receptor interactions.
Is Tesamorelin a peptide?
Yes. Tesamorelin is a synthetic modified peptide based on growth hormone-releasing hormone.
What form does Tesamorelin come in?
Research-grade Tesamorelin is commonly supplied as a lyophilized (freeze-dried) peptide.
What is the purity of Tesamorelin?
This product is specified at a minimum purity of ≥98%, subject to the applicable batch Certificate of Analysis.
Is Tesamorelin intended for human use?
No. This research-grade product is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.
How should Tesamorelin be stored?
The lyophilized peptide should be protected from heat, moisture, and direct sunlight and stored according to the manufacturer’s recommended conditions. Always refer to the batch-specific Certificate of Analysis for exact storage requirements.







Reviews
There are no reviews yet.